Objective: We hypothesized that neonates with bloody stools and concomitant eosinophilia are likely to have atopic enteropathy rather than necrotizing enterocolitis (NEC).
Introduction
Eosinophilia is diagnosed when the concentration of eosinophils in the blood exceeds the upper reference range limit. 1 Until recently, this upper limit was not well defined for neonates, allowing imprecision in defining eosinophilia and in identifying associations between it and various clinical conditions. Using laboratory values from over 63 000 neonates we recently reported the 5th and 95th percentile values for blood eosinophil concentrations at various gestational and postnatal ages. 2 The 95th percentile upper limit ranges from 1180 eosinophils ml À1 in the first week to about 1560 ml À1 after 3 weeks. 2 Given this more precise definition of neonatal eosinophilia, we commenced the present study of the association between bloody stools and eosinophilia.
When bloody stools are observed in a neonate, the possibility of necrotizing enterocolitis (NEC) enters the differential diagnosis. 3 We hypothesized that neonates with bloody stools and concomitant eosinophilia are likely to have atopic enteropathy, and thus are less likely to have NEC, pneumatosis intestinalis, a subsequent bowel resection for NEC and die from NEC. Our postulate was based on the assumption that eosinophilia suggests allergic enteropathy, and presages a more benign course and better outcome. We tested this hypothesis using cross-sectional data from a multihospital healthcare system.
Methods
The study was approved by the Intermountain Healthcare Institutional Review Board as a retrospective data study not requiring informed consent. The patient records eligible for review were restricted to those of neonates admitted to an Intermountain Healthcare NICU between 1 January 2005 and 30 June 30 2010. Intermountain Healthcare is a not-for-profit healthcare company that owns and operates 21 hospitals with labor and delivery services in Utah and Idaho.
Patient records were included in this study if the diagnosis of visible blood in the stool was identified anywhere in the electronic or paper medical record and validated using chart reviews, including 'bloody stool', 'hematochezia' or 'melena'. Patients were excluded from further consideration if they had a diagnosis of anal fissure listed in the medical record as the presumed reason for the blood in the stool. They were also excluded if they had only one laboratory test positive for heme in the stool, without visible blood in the stool specifically mentioned in the medical record.
Because complete blood counts (CBCs) were obtained on every neonate with a bloody stool, the group could be divided into two categories; 'eosinophil count elevated' versus 'eosinophil count normal'. CBCs were examined in the following way. First, the time of the bloody stool was determined from the nursing flow sheet. Second, if a CBC was done on that day, it was identified. If there was no CBC that day, a CBC within 72 h after passing the blood stool was sought. If there was no CBC on the day the bloody stools began, nor in the 72 h after these began, we sought a CBC in the 72 h period before the blood stools were passed. Eosinophilia was defined by an absolute eosinophil count (eosinophils ml À1 of blood) exceeding the 95th percentile upper reference limit according to postnatal age. This upper limit ranges from 1180 ml À1 during the first week to 1560 ml À1 after 3 weeks. 2 CBCs were performed using the Coulter LH 750 Hematology Analyzer (Beckman Coulter, Fullerton, CA, USA) according to Intermountain Healthcare clinical laboratory standard operating procedures.
The red blood cells (RBCs) transfused at the Intermountain Healthcare NICUs (with the exception of Primary Children's Medical Center) were supplied by the America Red Cross Blood Center, Salt Lake City, UT, USA. Blood was irradiated, leukoreduced, stored in citrate-phosphate-dextrose-adenine-1 and not washed before transfusion. The RBCs transfused at Primary Children's Medical Center NICU were supplied by Associated Regional and University Pathologists, Salt Lake City, UT, USA. The blood was irradiated, leukoreduced, stored in either citrate-phosphatedextrose-adenine-1 or occasionally Adsol. Blood was not washed unless an aliquot of >30 ml was provided from a unit greater than 5 days old.
Guidelines for administering RBC transfusions at the Intermountain Healthcare NICUs were initiated in 2002 and were revised in 2004. In brief, the guidelines recommend transfusion if the hematocrit falls below 35% for a patient on mechanical ventilation, below 27% for a patient on supplemental oxygen or with signs of anemia but not on mechanical ventilation and below 20% in any NICU patient. Compliance with these guidelines for the year 2006 was 70%, 4 and compliance for the year 2009 was 90%. 5 When NEC was identified, radiographic images, radiographic reports and physician's notes pertaining to NEC were reviewed. To document NEC, we used the criteria originally proposed by Bell et al., 6 as subsequently modified by Walsh et al. 7 and adopted by the Vermont Oxford Network. 8 This definition required the presence of one or more of the following three clinical signs; (1) bilious gastric aspirate or emesis, (2) abdominal distension and (3) occult or gross blood in stool (no fissure), and one or more of the following three radiographic findings; (1) pneumatosis intestinalis, (2) hepatobiliary gas and (3) pneumoperitoneum. Any cases with focal gastrointestinal perforations (spontaneous intestinal perforation) were not recorded as NEC.
Descriptive statistics were calculated. Student's t-test was used to assess group differences for continuous variables, and w 2 -test was used for categorical differences. A Fisher exact test was used to assess categorical difference when a group had five or fewer values. Statistical significance was set at P<0.05.
Results
During the 51/2 year period reviewed, 319 neonates were identified with bloody stools (Figure 1 ). Thirty-six of these had portions of their records what we judged as critical to this analysis that could not be located for confirmatory review and eight had what we judged as trivial bleeding occurrences ascribed to anorectal fissure.
Included in analysis 275

Bloody stools documented 319
No eosinophilia within 72 hours of bloody stool 221
Lack of clinical data available 36
Anal fissure 8 Eosinophilia within 72 hours of bloody stool 54 Figure 1 Study Group. The figure illustrates the distribution of patients included and excluded from analysis in this study.
The remaining 275 had the moniker 'bloody stools' used in the record. All 275 had one or more CBCs obtained during the 72 h surrounding the episode of bloody stools. Fifty-four had one or more eosinophil counts exceeding the 95th percentile reference range limit for age. The other 221 had all eosinophil counts falling within the reference range. Demographic features of the 54 neonates with bloody stools and eosinophilia were similar to the 221 with bloody stools and normal eosinophil counts, with the exceptions that the group with eosinophilia had been born at slightly earlier gestational ages and had a slightly lower (one point difference) in Apgar scores ( Table 1) .
The peak blood eosinophil counts within 72 h of the bloody stools were obviously higher in one group than the other; averaging four times higher ( Table 2) . Six of those with eosinophilia had counts that continued to climb even after 72 h, peaking at 3.1 ± 0.8 Â 10 3 ml À1 before declining to within the reference range.
Those with eosinophilia accompanying bloody stools were much more likely to have received a RBC transfusion in the 48 h before passing bloody stools (P<0.001). Contrary to our hypothesis, eosinophilia did not identify a group free of pneumatosis, NEC surgery or death from NEC ( Table 2 ). The only neonates with bloody stools and eosinophilia that went on to have NEC surgery or to die from NEC were in the group that had a transfusion preceding the bloody stools (Table 3) .
Maternal, neonatal and donor blood type were identified in the records of 17 of the 24 who received a RBC transfusion just before passing a bloody stool, and partial information was available on the other seven (shown in Supplementary Table 1 ). The distribution of all the examined antigens (A, B, O, AB and Rh) among this patient subset was similar to the antigens identified in the United States (using the white distribution because of the Caucasian predominance in our cohort). Highest eosinophil counts did not differ according to blood type. All transfused blood products were irradiated and leukoreduced, and no cases of graft-versus-host disease were suspected among the recipients.
In those with bloody stools and eosinophilia, feeding patterns before passing the bloody stools are shown in Table 4 . The group with no antecedent RBC transfusion had generally been fed a higher volume the day before passing bloody stools. This group also had trends toward receiving more calorically enriched feedings the day before bloody stools, and having human milk fortifier begun in the 72 h before passing bloody stools.
Among the 54 with eosinophilia and bloody stools, the 24 with a preceding RBC transfusion had a somewhat different pattern of change in eosinophil counts over the subsequent week. As shown in Figure 2 , those with an antecedent RBC transfusion (upper panel) tended to have increasing eosinophil counts, whereas those with 
Discussion
We initiated this study to test the hypothesis that among preterm infants with bloody stools, the finding of concomitant eosinophilia would distinguish allergic enterocolitis, a milder or more benign condition, from NEC. Gordon and Clark, 9 and Srinivasan and Brandler 10 recently provided a rationale for such. Specifically, in the Pediatrix Clinical Data Warehouse, about 10% of neonates with NEC had eosinophilia as defined by an eosinophil count X10% of circulating leukocytes. When compared with those with eosinophils <10%, the eosinophilic group tended to be of slightly lower gestation and birth weight, with a later onset of NEC, and a slightly lower death rate. 9 The speculation was made that allergic enterocolitis might habitually be underestimated as a cause of bloody stools in preterm infants.
In older infants the combination of bloody stools and eosinophilia suggests atopic conditions involving the bowel, such as allergic enterocolitis, 11 cow's milk allergy 12 or foodinduced eosinophilic proctocolitis. 13, 14 However, when bloody stools occur in a prematurely born infant cared for in a NICU, NEC must be a prime consideration, 15, 16 although, as suggested by Srinivasan et al. 11 , allergic enteropathy can be causative and can be difficult to distinguish from NEC. We aimed to further investigate this issue by applying a rigorous definition of eosinophilia 2 to all neonates with bloody stools identified in a multihospital database.
We hypothesized that neonates with bloody stools and eosinophilia were unlikely to develop radiographic pneumatosis (a reasonably well-recognized and relatively uniform finding in true NEC). We also hypothesized that they were unlikely to have bowel resection or to die from NEC (complications indicative of severe disease). In contrast to our hypothesis, the presence of eosinophilia did not identify a benign condition unique from NEC. Consistent with the data from Gordon and Clark, 9 this group had a lower gestational age and trended toward lighter birth weight. However, they had the same rates of pneumatosis intestinalis, bowel resection and death from NEC as those infants with normal eosinophil counts. On the basis of these findings, we caution clinicians that when bloody stools are observed in a NICU patient, the presence of eosinophilia does not reliably exclude NEC from the differential diagnosis, and such patients should be managed aggressively until the diagnosis of NEC is firmly rejected.
The function of eosinophils is still somewhat enigmatic, but clearly they are part of a network of cells involved in allergy, helminthiases and inflammation, and an elevation in their blood concentration is generally interpreted as evidence of a triggered immune response. 1, 17 We found that when neonates with bloody stools had eosinophilia they were more likely to have recently received a RBC transfusion. Juul et al. 18 also found eosinophilia in preterm infants following RBC transfusion, as did Bhat et al.
19 Table 4 Neonates with bloody stools and eosinophilia
Variable
RBC transfusion <48 h before passing bloody stools No RBC transfusion before passing bloody stools
P-value
Enteral intake the day before passing bloody stools (ml kg À1 per day) 93 ± 60 132 ± 37 0.014 Caloric density >20 cal per ounce on the day before passing blood stools (% yes) 50 77 0.055 Human milk fortifier newly begun within 72 h before passing bloody stools (% yes) 8 32 0.060 Exclusively human milk feedings the day before passing bloody stools (% yes) 38 18 0.146 Abbreviation: RBC, red blood cell. Enteral intake before passing bloody stools, categorized according to RBC transfusion history. Variables are organized according to descending order of P-value. Abbreviations: NEC, necrotizing enterocolitis; RBC, red blood cell. a The number of days after passing the bloody stools when 120 ml kg À1 per day of enteral intake was achieved. This analysis was limited to those that did not have bowel resection surgery. The findings are categorized according to whether or not a RBC transfusion was administered in the 48-h period before passing the blood stools. Variables are organized according to descending order of P-value.
Although this association has been made repeatedly, the responsible mechanism and significance remain unclear. Exposure of transfused neonates to foreign antigens on donor RBC cells might be involved in generating eosinophilia, as might medications or additives to which the neonates were co-exposed along with the transfusion. The association between RBC transfusion and the subsequent development of NEC is well documented. [20] [21] [22] [23] [24] [25] [26] [27] [28] Our current findings suggest that investigating eosinophils as participants in the pathogenesis of transfusionassociated NEC might be fruitful.
We realize several weaknesses in our study, largely derivative of the retrospective methodology. For instance, eosinophil counts were not performed according to a set research schedule and therefore eosinophilia might have been present but missed in patients who had few CBCs at the time of the bloody stool. Moreover, none of our cases had stool examined for the presence of eosinophils, but this would be an important addition for future prospective studies or transfusion-associated NEC registries. Moreover, we were unable to analyze cases according to the apparent amount of blood in the stool. Although all 275 had visible blood, all were identified in the records with the moniker of 'bloody stools' and some were charted as mild and others more severe; we could not compare these in a way that could be systematically analyzed. Moreover, the brand of fortifier used in each subject is not known, as this is not recorded in either the paper or electronic medical records. A last concern is the relative lack of racial and ethnic diversity among our patients, which may limit the applicability of these results to other populations.
We found that among neonates who pass bloody stools and have eosinophilia, only those with transfusion-associated NEC required NEC surgery or died from NEC. Their pattern of increasing eosinophil counts over the week following transfusion suggests a triggered immune response, perhaps by the transfusion itself or in combination with other immunogenic events occurring at that time and in a stereotypic manner to this patient population.
We speculate that patients with eosinophilia and no antecedent transfusion began as atopic enteropathy, 60% of whom progressed to pneumatosis and thus NEC. They were more likely to have recently been fed larger volumes, calorically dense feedings, been recently started on human milk fortifier, a static pattern of eosinophilia during the subsequent week and a milder clinical course, with no cases of NEC surgery or NEC death.
We do not know why eosinophil counts increase after neonatal RBC transfusion nor do we know the prevalence of this occurrence. 18, 19 Similarly, we do not know why eosinophil counts rise in transfusion-associated NEC, but we speculate it is related to this specific form of NEC pathogenesis. Despite these lacks in knowledge, the present study does add new information pertinent to NEC pathogenesis. Specifically, eosinophilia can be a part of the presentation of transfusion-associated NEC. This variety of NEC does not often associate with the use of fortifiers or large volume feedings, and when eosinophilia occurs in these patients the count generally continues to increase over several days. In contrast, cases that have eosinophilia and bloody stools but no antecedent RBC transfusion tend to have a benign course despite the presence of pneumatosis, and their eosinophilia tends to decrease once the feedings are stopped. The characterization of these NEC subsets needs to be verified in other data sets, but if confirmed it validates the global research strategy of reducing NEC into its composite etiologies as a means for improving clinical understanding, management and prevention. 
